CEO Josephs Paul purchases 17,000 shares of LFCR at $5.74; holds 559.7K shares post-transaction.
Josephs Paul, Chief Executive Officer, purchased 17,000 shares of LIFECORE BIOMEDICAL, INC. for $97,580.00, increasing his holdings from 542.7K shares to 559.7K shares (a 3.1% increase). The transaction occurred at $5.74 per share, below the current price of $5.80 and well below the 52-week high of $8.55, placing the purchase roughly 32.2% below the year's peak. The company reported $32.6M in quarterly revenue with net income of $-6.6M, and carries a P/E of 14.50 with a market cap of $214.7M, indicating ongoing losses offset by 24.2% year-over-year revenue growth. Over the preceding 90 days, the stock rallied 29.3%, though it declined 19.0% over the past 30 days, capturing the purchase near a recent local weakness following the recent advance.